Interestingly, tumor cells in oral CIS lesions exclusively produce hBD-3, correlated with expression of proliferating cell nuclear antigen (PCNA) in these cells (Kawsar et al., 2009). The gene discussed is PCNA; the disease is in situ carcinoma.